To Evaluate the Efficacy & Safety of an Defocus Lens in Slowing

Status Not yet recruiting

Clinical Trial Summary

To confirm the efficacy of DIMS lenses in controlling myopia progression, we planned a prospective, single-centre, randomised, double-blind, controlled, non-inferiority clinical study.

Clinical Trial Description

Prior to the trial, subjects signed an informed consent form, screened and qualified subjects were enrolled, and subjects received framed spectacles for correction of myopic refractive error in both eyes, and were fitted with framed spectacles by the investigator according to the standard fitting procedure specified in this protocol. Subjects were randomized to Trial Group A (strong high order aberration group) and Trial Group B (medium high order aberration group) and Control Group (HOYA MiYOSMART). The index of effectiveness in this clinical trial was to assess the effectiveness of the test group of lenses in slowing the rate of myopia progression by examining the subject's objective optometric values after ciliary muscle paralysis. The basic examination of this clinical trial included slit lamp examination, eye axis examination, fundus examination, corneal topography, best-corrected visual acuity, binocular visual function, refractive status and best-corrected visual acuity after ciliary muscle paralysis, and intraocular pressure measurements, etc. The spectacle fitting was also recorded, as well as the subjective feeling of the subjects when wearing the lenses. Each subject was followed up for 12 months, and the efficacy and safety of the test product for delaying the progression of myopia was evaluated by the investigator at 1 week ± 1 day (telephone follow-up), 1 month ± 15 days (telephone follow-up), 3 months ± 15 days, 6 months ± 15 days, and 12 months ± 30 days after wearing the lenses. During the course of this clinical trial, the lenses were replaced due to loss, breakage, change in refraction or poor vision with the lenses, etc., after evaluation by the investigator, and the changes were recorded. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06405711
Study type	Interventional
Source	Tianjin Eye Hospital
Contact	Xiaoqin Chen, MD
Phone	+8618202681988
Email	chenxq017@163.com
Status	Not yet recruiting
Phase	N/A
Start date	May 2024
Completion date	December 2026

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05919654` - Clinical Evaluation of MyoCare in Europe (CEME)	N/A
Recruiting	`NCT03402100` - Eye Drops Study for Myopia Control in Schoolchildren	N/A
Recruiting	`NCT03865160` - Low-dose Atropine for Myopia Control in Children	Phase 2/Phase 3
Recruiting	`NCT06088225` - Myopia Preventing With Distance-image Screen	N/A
Not yet recruiting	`NCT06085430` - Kubota Glass Parameter Refinement Study	N/A
Recruiting	`NCT05881655` - Slow Myopia Progression With Different Irradiance Light	N/A
Recruiting	`NCT05761379` - Clinical Study of Light Therapy to Control Myopia Progression in Children	N/A
Not yet recruiting	`NCT05760911` - Myopia Prevention Through Monitoring and Motivating Outdoor Activities With Smartwatches	N/A
Recruiting	`NCT04722874` - Repeated Low-Level Red-Light Therapy and Orthokeratology in Fast-progressing Myopia Control	N/A
Not yet recruiting	`NCT06221592` - Differences and Wearing Safety and Comfort of New Defocus Incorporated Multiple Segments Spectacle Lenses	N/A
Completed	`NCT04806711` - Eleven Years of Menicon Z Night Contact Lens Wear in Reducing Myopia Progression in Children	N/A
Completed	`NCT04806763` - Myopia Control With Orthokeratology Contact Lenses in Spain	N/A
Completed	`NCT04806698` - Long-term Efficacy of Orthokeratology Contact Lens Wear in Controlling the Progression of Childhood Myopia	N/A
Recruiting	`NCT05894382` - Double Helix Design Defocus Lens Spectacle (RACE) for Myopia Control	N/A
Completed	`NCT05683535` - Adverse Events Related to Low Dose Atropine
Completed	`NCT05300321` - DIMS-myopia Progression ADN Axial Length Growth	N/A
Withdrawn	`NCT03519490` - Can Distance Center and Near Center Multifocal Contact Lenses Control Myopia Progression in Children?	N/A
Completed	`NCT05372991` - Safety, Tolerability and Pharmacodynamics Evaluation of CBT-009 Eye Drop	Phase 1/Phase 2
Active, not recruiting	`NCT05373693` - Myopia-control Efficacy by Peripheral Defocus Lens (PDL)	N/A
Completed	`NCT05007626` - Near Horizontal Heterophoria in Chinese Children

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

To Evaluate the Efficacy and Safety of an Defocus Lens in Slowing the Progression of Myopia

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms